Cardiovascular
Ethnic differences in the association between age at diagnosis of diabetes and the risk of cardiovascular complications: a population-based cohort study
Sep
Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia. 2021;64(2):275–87.
Google Scholar
Sattar N, Rawshani A, Franzén S, Rawshani A, Svensson AM, Rosengren A, et al. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation. 2019;139(19):2228–37.
Google Scholar
Hillier TA, Pedula KL. Complications in young adults with early-onset type 2 diabetes. Diabetes Care. 2003;26(11):2999–3005.
Google Scholar
Chan JCN, Lau ESH, Luk AOY, Cheung KKT, Kong APS, Yu LWL, et al. Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis. Am J Med. 2014;127(7):616–24.
Google Scholar
Zoungas S, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57(12):2465–74.
Google Scholar
Morton JI, Lazzarini PA, Polkinghorne KR, Carstensen B, Magliano DJ, Shaw JE. The association of attained age, age at diagnosis, and duration of type 2 diabetes with the long-term risk for major diabetes-related complications. Diabetes Res Clin Pract. 2022;190:110022.
Google Scholar
Morton JI, Liew D, McDonald SP, Shaw JE, Magliano DJ. The association between age of onset of type 2 diabetes and the long-term risk of end-stage kidney disease: a national registry study. Diabetes Care. 2020;43(8):1788–95.
Google Scholar
Shen B, Li Y, Sheng CS, Liu L, Hou T, Xia N, et al. Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: results from a longitudinal cohort and mendelian randomization study. The Lancet Regional Health—Western Pacific. 2023. https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(22)00211-5/fulltext. Accessed 1 Jun 2023
Barbiellini Amidei C, Fayosse A, Dumurgier J, Machado-Fragua MD, Tabak AG, van Sloten T, et al. Association between age at diabetes onset and subsequent risk of dementia. JAMA. 2021;325(16):1640–9.
Google Scholar
Ke C, Narayan KMV, Chan JCN, Jha P, Shah BR. Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations. Nat Rev Endocrinol. 2022;4(18):413–32.
Google Scholar
Lipscombe LL, Hwee J, Webster L, Shah BR, Booth GL, Tu K. Identifying diabetes cases from administrative data: a population-based validation study. BMC Health Serv Res. 2018;2(18):316.
Google Scholar
Weisman A, Tu K, Young J, Kumar M, Austin PC, Jaakkimainen L, et al. Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada. BMJ Open Diab Res Care. 2020;8(1):e001224.
Google Scholar
Shah BR, Chiu M, Amin S, Ramani M, Sadry S, Tu JV. Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study. BMC Med Res Methodol. 2010;15(10):42.
Google Scholar
Statistics Canada, Government of Canada. 2016 Census topic: immigration and ethnocultural diversity. Ottawa: Statistics Canada. 2017. http://www12.statcan.gc.ca/census-recensement/2016/rt-td/imm-eng.cfm. Accessed 6 Jun 2023.
Austin PC. Using the standardized difference to compare the prevalence of a binary Variable between two groups in observational research. Commun Stat—Simul Comput. 2009;38(6):1228–34.
Google Scholar
Austin PC. The performance of different propensity score methods for estimating marginal hazard ratios. Stat Med. 2013;32(16):2837–49.
Google Scholar
Shah BR, Victor JC, Chiu M, Tu JV, Anand SS, Austin PC, et al. Cardiovascular complications and mortality after diabetes diagnosis for South Asian and Chinese patients. Diabetes Care. 2013;36(9):2670–6.
Google Scholar
Khan NA, Wang H, Anand S, Jin Y, Campbell NRC, Pilote L, et al. Ethnicity and sex affect diabetes incidence and outcomes. Diabetes Care. 2011;34(1):96–101.
Google Scholar
Woodward M, Patel A, Zoungas S, Liu L, Pan C, Poulter N, et al. Does glycemic control offer similar benefits among patients with diabetes in different regions of the world?: results from the ADVANCE trial. Diabetes Care. 2011;34(12):2491–5.
Google Scholar
Huo X, Gao L, Guo L, Xu W, Wang W, Zhi X, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol. 2016;4(2):115–24.
Google Scholar
Bragg F, Halsey J, Guo Y, Zhang H, Yang L, Sun X, et al. Blood pressure and cardiovascular diseases in Chinese adults with type 2 diabetes: a prospective cohort study. The lancet regional health—western pacific. 2021. https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(20)30085-7/fulltext. Accessed 6 Jun 2022
Davis TME, Coleman RL, Holman RR. Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83). Diabet Med. 2014;31(2):200–7.
Google Scholar
Shah BR, Cauch-Dudek K, Anand SS, Austin PC, Manuel DG, Hux JE. Absence of disparities in the quality of primary diabetes care for South Asians and Chinese in an urban Canadian setting. Diabetes Care. 2012;35(4):794–6.
Google Scholar
Prasad RB, Asplund O, Shukla SR, Wagh R, Kunte P, Bhat D, et al. Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver. Diabetologia. 2022;65(1):65–78.
Google Scholar
Ahlqvist E, Storm P, Käräjämäki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361–9.
Google Scholar
Tanabe H, Saito H, Kudo A, Machii N, Hirai H, Maimaituxun G, et al. Factors associated with risk of diabetic complications in novel cluster-based diabetes subgroups: a Japanese retrospective cohort Study. J Clin Med. 2020;9(7):2083.
Google Scholar
Ko DT, Sivaswamy A, Sud M, Kotrri G, Azizi P, Koh M, et al. Calibration and discrimination of the Framingham risk score and the pooled cohort equations. CMAJ. 2020;192(17):E442–9.
Google Scholar
Zhang Y, Miao H, Chia YC, Buranakitjaroen P, Siddique S, Shin J, et al. Cardiovascular risk assessment tools in Asia. J Clin Hypertens. 2022;24(4):369–77.
Google Scholar
Luk AOY, Lau ESH, So WY, Ma RCW, Kong APS, Ozaki R, et al. Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes. Diabetes Care. 2014;37(1):149–57.
Google Scholar
Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 2019;7(6):442–51.
Google Scholar
Ke CH, Morgan S, Smolina K, Gasevic D, Qian H, Khan NA. Is cardiovascular risk reduction therapy effective in South Asian, Chinese and other patients with diabetes? A population-based cohort study from Canada. BMJ Open. 2017;7(8):e013808.
Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2021;13(372):m4573.
Google Scholar
Yang YS, Chen HH, Huang CN, Hsu CY, Hu KC, Kao CH. GLP-1RAs for Ischemic stroke prevention in patients with type 2 diabetes without established atherosclerotic cardiovascular disease. Diabetes Care. 2022;45(5):1184–92.
Google Scholar
Arslanian SA, Hannon T, Zeitler P, Chao LC, Boucher-Berry C, Barrientos-Pérez M, et al. Once-weekly dulaglutide for the treatment of youths with type 2 diabetes. New Engl J Med. 2022;387:433.
Google Scholar
Lee MMY, Ghouri N, McGuire DK, Rutter MK, Sattar N. Meta-analyses of results from randomized outcome trials comparing cardiovascular effects of SGLT2is and GLP-1RAs in Asian versus white patients with and without type 2 diabetes. Diabetes Care. 2021;44(5):1236–41.
Google Scholar
Ke C, Lipscombe LL, Weisman A, Zhou L, Austin PC, Shah BR, et al. Change in the Relation Between Age and Cardiovascular Events Among Men and Women With Diabetes Compared With Those Without Diabetes in 1994–1999 and 2014–2019: A Population-Based Cohort Study. Diabetes Care. 2023;dc230952
Ke C, Lipscombe LL, Weisman A, Zhou L, Austin PC, Shah BR, et al. Trends in the Association Between Diabetes and Cardiovascular Events, 1994-2019. JAMA. 2022;328(18):1866–9.
Ke C, Luk AO, Chan JCN, Wei X, Shah BR. Migration and diabetes incidence among Chinese adults in Canada, China, Hong Kong, and Taiwan: an international population-based comparative study from 2000 to 2017. Diabetes Res Clin Pract. 2021;180:109062.
Google Scholar
Wang L, Xing Y, Yu X, Ming J, Liu X, Li X, et al. Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: a cross-sectional study. J Diabetes Investig. 2020;11(5):1285–94.
Google Scholar
Malik MO, Govan L, Petrie JR, Ghouri N, Leese G, Fischbacher C, et al. Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland. Diabetologia. 2015;58(4):716–25.
Google Scholar
Ke C, Sohal P, Qian H, Quan H, Khan NA. Diabetes in the young: a population-based study of South Asian. Chinese and White people Diabet Med. 2015;32(4):487–96.
Google Scholar
Luk AOY, Ke C, Lau ESH, Wu H, Goggins W, Ma RCW, et al. Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: a retrospective cohort study. PLoS Med. 2020;17(2):e1003052.
Google Scholar
